Cargando…
Epigenetic Insights and Potential Modifiers as Therapeutic Targets in β–Thalassemia
Thalassemia, an inherited quantitative globin disorder, consists of two types, α– and β–thalassemia. β–thalassemia is a heterogeneous disease that can be asymptomatic, mild, or even severe. Considerable research has focused on investigating its underlying etiology. These studies found that DNA hypom...
Autores principales: | Zakaria, Nur Atikah, Islam, Md Asiful, Abdullah, Wan Zaidah, Bahar, Rosnah, Mohamed Yusoff, Abdul Aziz, Abdul Wahab, Ridhwan, Shamsuddin, Shaharum, Johan, Muhammad Farid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8158146/ https://www.ncbi.nlm.nih.gov/pubmed/34070036 http://dx.doi.org/10.3390/biom11050755 |
Ejemplares similares
-
Genetic Manipulation Strategies for β-Thalassemia: A Review
por: Zakaria, Nur Atikah, et al.
Publicado: (2022) -
Next-Generation Sequencing (NGS) and Third-Generation Sequencing (TGS) for the Diagnosis of Thalassemia
por: Hassan, Syahzuwan, et al.
Publicado: (2023) -
Characterisation of Primary Human Hippocampal Astrocyte Cell Culture Following Exposure to Hypoxia
por: Nor Nazli, Nurul Atikah, et al.
Publicado: (2023) -
Transcriptomic Profiles of MV4-11 and Kasumi 1 Acute Myeloid Leukemia Cell Lines Modulated by Epigenetic Modifiers Trichostatin A and 5-Azacytidine
por: Asmaa, Mat Jusoh Siti, et al.
Publicado: (2020) -
Ageing, Drosophila melanogaster and Epigenetics
por: Halim, Mardani Abdul, et al.
Publicado: (2020)